Home / Pharmaceutical company intelligence
Stanley Pharmaceuticals (Pvt) Ltd, logo
Pharmaceutical company intelligence

Stanley Pharmaceuticals products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Peshawar · Pakistan

Peshawar-based pharmaceutical manufacturer incorporated in 1995 with solid and liquid dosage-form manufacturing facilities.

Stanley Pharmaceuticals products in Pakistan

Stanley Pharmaceuticals (Pvt) Ltd has 60 medicine presentations registered in Pakistan under 31 brands, covering 28 generic medicines. Most of its products are in Pain & musculoskeletal, Anti-infectives and Vitamins, minerals & nutrition. Its brands with the most registered strengths and packs are Pedrol (Paracetamol), Fenbro (Ibuprofen), Riam (Metronidazole) and Lorid (Loratadine). 60 products have an official DRAP price on MedInfoBase. See all 31 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation13 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Oct 2026Latest source-check date across this published portfolio
Latest effective price date29 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Stanley Pharmaceuticals (Pvt.) Limited
Company type
Private pharmaceutical manufacturer
Address
84-B Industrial Estate, Hayatabad, Peshawar, Pakistan
Phone
+92 91 5817468-9
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000434 Stanley Pharmaceuticals (Pvt) Ltd. · Khyber Pakhtunkhwa
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000434 60 linked products · source seen 13 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx65public portfolio records represented
REG50unique registrations represented
IDX2indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER29registry-verified exact registrations
PKR60current validated price records
G28generic molecules in indexed catalogue
DF7dosage-form groups
TA6therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage92%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage68%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixStanley Pharmaceuticals (Pvt) Ltd,Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/stanley-pharmaceuticals-pvt-ltdGenerated 13 Nov 2026Pain & musculoskeletal22 · 37%Anti-infectives19 · 32%Vitamins, minerals & nutrition11 · 18%Respiratory & allergy4 · 7%Gastrointestinal & hepatology3 · 5%Reproductive & genitourinary1 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioStanley Pharmaceuticals (Pvt) Ltd,Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/stanley-pharmaceuticals-pvt-ltdGenerated 13 Nov 202660presentationsSuspension24 · 40%Tablet22 · 37%Capsule7 · 12%Syrup4 · 7%Drops1 · 2%Other1 · 2%Other forms1 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionStanley Pharmaceuticals (Pvt) Ltd,Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/stanley-pharmaceuticals-pvt-ltdGenerated 13 Nov 202641comparable productsBelow peer median10 · 24%Near peer median15 · 37%Above peer median16 · 39%Company median price position+0.0%Lowest-price equivalents1Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsStanley Pharmaceuticals (Pvt) Ltd,Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/stanley-pharmaceuticals-pvt-ltdGenerated 13 Nov 2026Shaigan Pharmaceuticals (Pvt) Ltd12 shared43% overlapBryon Pharmaceuticals (Pvt.) Ltd12 shared43% overlapHizat Pharmaceutical Industry12 shared43% overlapMediate Pharmaceutical Pvt Ltd11 shared39% overlapGlobal Pharmaceuticals (Pvt.) Ltd.11 shared39% overlapValor Pharmaceuticals11 shared39% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Suspension24 products
Tablet22 products
Capsule7 products
Syrup4 products
Drops1 products
Other1 products
Solution1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Stanley Pharmaceuticals (Pvt) Ltd, is priced against the market

41 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers45Distinct registrations among indexed, published, presentation-validated products only
Verified price observations60
Products with a verified price60
Products with multiple price observations0
Source records with multiple versions60
Latest portfolio source check12 Oct 2026
Latest effective price date29 Jul 2026
Latest source observation13 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

50 unique registration(s) · 2 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Rozid Ciprofloxacin 250 mg Tablet 10s 032007 PKR 240.05 PKR 24.01/tablet 🔒 Pharma Pro
Rozid Ciprofloxacin 500 mg Tablet 10s 032008 PKR 480.11 PKR 48.01/tablet 🔒 Pharma Pro
A to Z

All 31 Stanley Pharmaceuticals brands in Pakistan

  • Abex-C Vit A · 25000 IU capsule
  • Bendazol Albendazole · 200 mg suspension, 200 mg tablet
  • Calsid Tricalcium phosphate + Vitamin D, Calcium phosphate + Calcium lactate + Vitamin D · 210 mg + 350 IU/5 mL oral liquid, 325 mg + 162 mg + 500 IU tablet
  • Clozim-1 Clotrimazole · 500 mg tablet
  • Clozim-6 Clotrimazole · 100 mg tablet
  • F-S Ferrous sulfate · 100 mg/5 mL solution
  • Fenbro Ibuprofen · 100 mg/5 mL suspension, 200 mg/5 mL suspension, 400 mg tablet
  • Ferfolic Ferrous sulfate + Folic acid · 200 mg + 0.1 mg capsule
  • Fervit Ferrous sulfate + Folic acid + Ascorbic acid + Thiamine + Riboflavin + Pyridoxine + Nicotinamide · 2 mg + 2 mg + 1 mg + 0.5 mg + 10 mg + 150 mg + 50 mg capsule
  • Fervit Liquid Thiamine (B1) + Riboflavin (B2) + Pyridoxine (B6) + Cyanocobalamin (B12) + Calcium D-pantothenate + Nicotinamide + Ferrous sulfate + Vitamin C · 1.5 mg + 1.5 mg + 1.25 mg + 6.25 mcg + 2.5 mg + 7.5 mg + 131 mg + 125 mg/5 mL syrup
  • Furamid Furazolidone + Metronidazole, Metronidazole · 100 mg + 300 mg tablet, 25 mg/5 mL suspension
  • Hex Clomifene citrate · 50 mg tablet
  • Liverad L-Ornithine L-Aspartate + Nicotinamide + Riboflavin-5-phosphate sodium · 300 mg + 24 mg + 0.76 mg/5 mL syrup
  • Lorid Loratadine · 10 mg tablet, 5 mg/5 mL suspension
  • Multonic Thiamine (B1) + Riboflavin (B2) + Pyridoxine (B6) + Cyanocobalamin (B12) + Vitamin A + Nicotinamide + Vitamin D + Vitamin C · 1.5 mg + 1.2 mg + 1 mg + 3 mcg + 3000 IU + 10 mg + 400 IU + 50 mg/5 mL syrup
  • Pedrol Paracetamol · 120 mg suspension, 120 mg/5 mL suspension, 250 mg/5 mL suspension
  • Pedrol CF Paracetamol + Pseudoephedrine + Chlorpheniramine · 500 mg + 60 mg + 4 mg tablet
  • Pedrol Extra Paracetamol · 500 mg tablet
  • Perl Omeprazole · 20 mg capsule
  • Perl DS Omeprazole · 40 mg capsule
  • Riam Metronidazole · 200 mg/5 mL suspension, 400 mg tablet
  • Rid All Orphenadrine Citrate · 35 mg tablet
  • Rid-All Forte Paracetamol + Orphenadrine · 50 mg + 650 mg tablet
  • Ridox Doxycycline · 100 mg capsule
  • Rozid Ciprofloxacin · 250 mg tablet, 500 mg tablet
  • Stanzith Azithromycin · 250 mg capsule, 500 mg tablet
  • Vasedex L Thiamine (B1) + Riboflavin (B2) + Pyridoxine (B6) + Cyanocobalamin (B12) + Calcium D-pantothenate + Nicotinamide + Inositol + Lysine HCl + Vitamin C · 4.16 mg + 1.66 mg + 1 mg + 8.33 mcg + 2.5 mg + 18 mg + 5 mg + 33.33 mg + 75 mg/5 mL syrup
  • Vigon Vitamin A · 30000 IU tablet
  • Vitace Ascorbic acid · 500 mg tablet
  • Zolt Metronidazole, Metronidazole + Diloxanide furoate · 200 mg tablet, 250 mg/10 mL + 250 mg/10 mL suspension
  • Zolt DS Metronidazole + Diloxanide furoate · 400 mg + 500 mg tablet
Questions

Stanley Pharmaceuticals: common questions

How many products does Stanley Pharmaceuticals have in Pakistan?

Stanley Pharmaceuticals (Pvt) Ltd has 60 registered medicine presentations in Pakistan, sold under 31 brands and covering 28 generic medicines.

What are the main brands of Stanley Pharmaceuticals?

By number of registered strengths and packs, its largest brands are Pedrol (Paracetamol), Fenbro (Ibuprofen), Riam (Metronidazole), Lorid (Loratadine) and Zolt (Metronidazole, Metronidazole + Diloxanide furoate). This is not a sales ranking.

Which therapy areas does Stanley Pharmaceuticals cover?

The most products are in Pain & musculoskeletal (22), Anti-infectives (19), Vitamins, minerals & nutrition (11), Respiratory & allergy (4) and Gastrointestinal & hepatology (3).

Where can I see Stanley Pharmaceuticals medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Stanley Pharmaceuticals (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 13, 2026, from https://medinfobase.com/company/stanley-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9